← Search

Data · dataset · 2025

Crizanlizumab

Listed in Virginia Open Data Portal

Adakveo (crizanlizumab) is a prescription biologic medication manufactured by Novartis Pharmaceuticals Corporation.

Description

It acts as a P-selectin blocker to help manage certain conditions. Administered intravenously as an injection at 10 mg/mL strength.

This information was generated using AI and is provided for informational and research purposes only. --- ### 🔗 Related Datasets - Crizanlizumab — *HealthData.Gov* - Vedolizumab — *HealthData.Gov* - Adalimumab-aqvh — *HealthData.Gov* - Vedolizumab — *HealthData.Gov* - Inebilizumab — *HealthData.Gov* ---

Links

Where it is published

Documentation and papers

Catalogue records · 1

Topics

From keywords
Medicine & Health
Provenance · 1 source records, 6 field assertions
SourceKeyLast seenRaw
Virginia Open Data Portalf882305a-39fb-4692-8f84-1f6e9b325cae3 h agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].local:field:medicine-healthmapping · data virginia govconnector:data_virginia_gov@1.0.0
created_datesource · data virginia govconnector:data_virginia_gov@1.0.0
descriptionsource · data virginia govconnector:data_virginia_gov@1.0.0/notes
publication_datesource · data virginia govconnector:data_virginia_gov@1.0.0
titlesource · data virginia govconnector:data_virginia_gov@1.0.0/title
updated_datesource · data virginia govconnector:data_virginia_gov@1.0.0